Health

US FDA rejects EUA for Covaxin, recommends Biologics Licence Application route for approval-India News , Firstpost

Coronavirus Live News Update: Bharat Biotech’s US partner Ocugen Inc announced in a statement Thursday that it would pursue the submission of Covaxin’s BLA in accordance with the FDA’s recommendations.

Coronavirus Latest news update: Frustration of Bharat Biotech COVID-19 (New Coronavirus Infection) U.S. Food and Drug Administration Vaccine Covaxin has told Indian vaccine maker U.S. partner Ocugen Inc to choose a Biopharmacy Approval Application (BLA) route with additional data denying the desire for an emergency use authorization. “Recommended”.

every day COVID-19 (New Coronavirus Infection) India’s numbers fell below Rs 10,000 for the fourth straight day, with 91,702 new cases reported, but the daily positive rate dropped to 4.49 percent, according to federal Ministry of Health data updated Friday. ..

In fresh cases, the total number of cases increased to 2,92,74,823.Is COVID-19 (New Coronavirus Infection) The casualties amounted to 3,63,079 and 3,403 new deaths.According to the data updated at 8 am

Active cases further decreased to 11,21,671 and accounted for 3.83% of all infectious diseases. COVID-19 (New Coronavirus Infection) The recovery rate improved to 94.93%. 46,281 net losses have been recorded COVID-19 (New Coronavirus Infection) Case load in a 24-hour span.

In addition, 20,44,131 tests were conducted on Thursday, and the total of cumulative tests conducted so far was detected. COVID-19 (New Coronavirus Infection) In the country it is 37,42,42,384.

The daily positive rate was recorded at 4.49 percent. According to the ministry, it has been below 10% for 18 consecutive days, and the weekly positive rate has dropped to 5.14%.

Recovery continues to outpace daily new cases for 29 consecutive days. According to the data, the number of people who recovered from the disease surged to 2,77,90,073 and the case fatality rate increased to 1.24 percent. Cumulatively 24, 60, 85, 649 COVID-19 (New Coronavirus Infection) Vaccine doses have been administered under the promotion of national vaccination.

India COVID-19 (New Coronavirus Infection) Tally exceeded 20 Rakı on August 7, 30 Rakı on August 23, 40 Rakı on September 5, and 50 Rakı on September 16. It exceeded 60 Rakı on September 28, 70 Rakı on October 11, 80 Rakı on October 29, 90 Rakı on November 20, and 1 crawl on December 19. India crossed a tough milestone of Rs 200 million on May 4th.

The 3,403 new deaths include 1,915 from Maharashtra, 358 from Tamil Nadu, and 194 each from Karnataka and Kerala.

A total of 1,03,748 from Maharashtra, 32,485 from Karnataka, 28,528 from Tamil Nadu, 24,748 from Delhi, 21,597 from Uttar Pradesh, 16,642 from West Bengal, 15,367 from Punjab and 13,285. 3,63,079 deaths have been reported domestically. From Chhattisgarh.

The ministry emphasized that more than 70 percent of deaths were caused by comorbidity. “Our numbers are coordinated with the Indian Medical Research Council,” the ministry said on its website, adding that the distribution of numbers by state is subject to further verification and adjustment.

US FDA rejects EUA for Covaxin, recommends Biologics Licence Application route for approval-India News , Firstpost Source link US FDA rejects EUA for Covaxin, recommends Biologics Licence Application route for approval-India News , Firstpost

Related Articles

Back to top button